Intralesional interleukin-2 augmentation therapy in treatment-refractory melanoma.
Le ST, Ji-Xu A, Liakos W, Toussi AM, Cheng MY, Ma C, Wang EA, Wilken R, Boddu S, Downing L, Kao J, Davis JR, Monjazeb AM, Fung MA, Konia TH, Maverakis E, Kirane AR.
Le ST, et al. Among authors: wilken r.
Dermatol Ther. 2022 Nov;35(11):e15853. doi: 10.1111/dth.15853. Epub 2022 Oct 6.
Dermatol Ther. 2022.
PMID: 36151592
No abstract available.